Breadcrumb Home Bristol-Myers Squibb Politics & Policy PBM bills drove lobbying spending in 2023 Patient Care CVS Caremark returns Eliquis to formulary after outcry Executive Compensation Less risk, more retention: How the COVID-19 pandemic has changed how healthcare execs get paid Patient Care Two pharma giants commit $100M each in part to promote diversity in clinical trials Finance Bristol-Myers Squibb buying Celgene in $74B deal Technology Some immune-boosting cancer drugs may pose rare heart risks Finance Cancer drug sales boost Bristol-Myers Squibb performance Providers Accuracy of Open Payments data still being debated Finance Bristol-Myers drug fails lung cancer study, shares plunge Finance Pfizer beats Street 2Q forecasts despite big drop in profit Load More Sponsored Content
